Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.

[1]  M. Marton,et al.  Development of a PCR Assay to Detect Low Level Trypanosoma cruzi in Blood Specimens Collected with PAXgene Blood DNA Tubes for Clinical Trials Treating Chagas Disease , 2016, PLoS neglected tropical diseases.

[2]  S. Palma,et al.  Current drug therapy and pharmaceutical challenges for Chagas disease. , 2016, Acta tropica.

[3]  P. Hotez,et al.  The BENEFIT Trial: Where Do We Go from Here? , 2016, PLoS neglected tropical diseases.

[4]  J. Concepción,et al.  Detection of Trypanosoma cruzi by Polymerase Chain Reaction. , 2016, Methods in molecular biology.

[5]  J. Ramírez,et al.  New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients , 2015, Antimicrobial Agents and Chemotherapy.

[6]  A. Ciapponi,et al.  Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies , 2015, PloS one.

[7]  S. Yusuf,et al.  Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. , 2015, The New England journal of medicine.

[8]  M P Busch,et al.  Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity , 2015, European journal of heart failure.

[9]  J. Urbina,et al.  Population Pharmacokinetics of Benznidazole in Adult Patients with Chagas Disease , 2015, Antimicrobial Agents and Chemotherapy.

[10]  P. Hotez,et al.  Evidence of autochthonous Chagas disease in southeastern Texas. , 2015, The American journal of tropical medicine and hygiene.

[11]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[12]  P. Hotez,et al.  Development of chagas cardiac manifestations among Texas blood donors. , 2015, The American journal of cardiology.

[13]  Chagas disease in Latin America: an epidemiological update based on 2010 estimates. , 2015, Releve epidemiologique hebdomadaire.

[14]  D. Fabbro,et al.  Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas , 2014, PLoS neglected tropical diseases.

[15]  M. Miles,et al.  Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity , 2014, Memorias do Instituto Oswaldo Cruz.

[16]  G. Guyatt,et al.  Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. , 2014, The Cochrane database of systematic reviews.

[17]  Fernando Salvador,et al.  Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. , 2014, The New England journal of medicine.

[18]  J. Ramsey,et al.  Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review , 2014, Expert review of anti-infective therapy.

[19]  A. Ribeiro,et al.  Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects , 2013, PloS one.

[20]  J. Urbina,et al.  Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments , 2013, PLoS neglected tropical diseases.

[21]  M. Waterman,et al.  In Vitro and In Vivo Studies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi , 2013, Antimicrobial Agents and Chemotherapy.

[22]  R. López-Vélez,et al.  Lack of association between blood-based detection of Trypanosoma cruzi DNA and cardiac involvement in a non-endemic area , 2011, Annals of tropical medicine and parasitology.

[23]  J. Marin Neto,et al.  I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo , 2011 .

[24]  A. Assal,et al.  International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients , 2011, PLoS neglected tropical diseases.

[25]  R. López-Vélez,et al.  Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. , 2009, The Journal of antimicrobial chemotherapy.

[26]  C. Britto.  Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. , 2009, Memorias do Instituto Oswaldo Cruz.

[27]  A. Romanha,et al.  Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up. , 2009, Memorias do Instituto Oswaldo Cruz.

[28]  P. Leiva.  Faculty Opinions recommendation of Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. , 2008 .

[29]  Robert H Gilman,et al.  Evaluation and treatment of chagas disease in the United States: a systematic review. , 2007, JAMA.

[30]  B. Maciel,et al.  Pathogenesis of Chronic Chagas Heart Disease , 2007, Circulation.

[31]  A. C. Campos-de-Carvalho,et al.  Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations , 2005, Antimicrobial Agents and Chemotherapy.

[32]  O. Salomone,et al.  Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction , 2003, Heart.

[33]  C. Carneiro,et al.  Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. , 2001, Memorias do Instituto Oswaldo Cruz.

[34]  O. Martins-Filho,et al.  A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. , 2000, The Journal of antimicrobial chemotherapy.

[35]  P. Wincker,et al.  Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. , 1995, The American journal of tropical medicine and hygiene.

[36]  E. Segura,et al.  Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. , 1994, American heart journal.

[37]  R. Isturiz,et al.  Chagas Disease , 2021, Neglected Tropical Diseases.

[38]  M Nurminen,et al.  Comparative analysis of two rates. , 1985, Statistics in medicine.